Fayette Cnty Drug/Alc Commission Inc SCA
-
Services:
- Treatment for other addiction disorder
- Treatment for gambling disorder
- No formal relationship with prescribing entity
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- State Substance use treatment agency
- Opioids detoxification
- Medication routinely used during detoxification
- Alcohol Detoxification
- Sign language services for the deaf and hard of hearing
- Private non-profit organization
- Case management service
- Motivational interviewing
- Cognitive behavioral therapy
- Anger management
- Telemedicine/telehealth therapy
- 12-step facilitation
- Relapse prevention
- Brief intervention
- Substance use disorder counseling
- Screening for tobacco use
- Screening for substance use
- Outreach to persons in the community
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Vaping permitted in designated area
- Self-help groups
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- Male
- Female
- Group counseling
- Family counseling
- Individual counseling
- Marital/couples counseling
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Specially designed program for DUI/DWI clients
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Outpatient detoxification
- Adolescents
- Young adults
- Adult men
- Clients with co-occurring mental and substance use disorders
- Clients with co-occurring pain and substance use disorders
- Seniors or older adults
- Adult women
- Criminal justice (other than DUI/DWI)/Forensic clients
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Buprenorphine detoxification
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes naltrexone
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
- Aftercare/continuing care
- Substance use treatment
- Detoxification
- Medication for mental disorders
- Nicotine replacement
- Clonidine
- Acamprosate (CampralĀ®)
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Disulfiram
- Non-nicotine smoking/tobacco cessation
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Cash or self-payment
- Medicaid
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- State-financed health insurance plan other than Medicaid
- No formal relationship with prescribing entity
- Smoking permitted in designated area
- HIV testing
- Drug or alcohol urine screening
- STD testing
- Drug and alcohol oral fluid testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Testing for Hepatitis B (HBV)
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
Other Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Opioid Medications used in Treatment
License/Certification/Accreditation
Detoxification (medical withdrawal) Services
Language Services
Facility Operation (e.g., Private, Public)
Ancillary Services
Treatment Approaches
Assessment/Pre-treatment
Facility Vaping Policy
Recovery Support Services
Gender Accepted
Education and Counseling Services
Exclusive Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Type of Opioid Treatment
Transitional Services
Type of Care
Pharmacotherapies
Payment/Insurance/Funding Accepted
External Opioid Medications Source
Facility Smoking Policy
Testing
Type of Alcohol Use Disorder Treatment